This is the main objective of a research project involving scientists from Università Cattolica del Sacro Cuore, campus di  Roma e della Fondazione Policlinico Universitario A. Gemelli IRCCS insieme a Sapienza Università di Roma and the University of Limoges. The project, called “MULTIPROBE,” has won the prestigious ERC Synergy Grant 2025 funding. A second ERC grant in this category was awarded to a researcher from the Facoltà di Lettere e Filosofia at Università Cattolica del Sacro Cuore, Milan.

Radiotherapy can be safely omitted as a treatment for many breast cancer patients who have had a mastectomy and are taking anti-cancer drugs, a study shows.

In the United States, the incarcerated population is aging. About 15% of incarcerated adults, or approximately 175,000 people, are now 55 years or older. As the incarcerated population ages, cancer has become one of the greatest threats to their health. And despite the growing prevalence, cancer outcomes among those incarcerated are worse than for those with no history of incarceration. 

In a new study, Yale researchers investigated the quality of cancer care received by people diagnosed with cancer during and immediately after incarceration — and whether differences in access to care might explain some of the mortality gaps. They found that people who had a cancer diagnosed during a period of incarceration, or shortly after their release, were less likely to receive prompt, guideline-recommended cancer care.

The findings are published in the journal JAMA Network Open.